Volker Haucke awarded Academia Europaea membership

    -     Deutsch

  • Prospective Students
  • Students and Doctorate
  • Alumni and Supporters
  • Continuing Education

Prof. Volker Haucke, director of the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), professor of molecular pharmacology at Freie Universität, and member of the NeuroCure cluster of excellence, has been elected to the Academia Europaea

No 259/2019 from Sep 06, 2019

The Academia Europaea is a European non-governmental association that functions as an academy. Its members are scholars, scientists, and researchers who work together to promote learning, education, and research. The Academia Europaea, based in London, was founded in 1988 on the initiative of the Royal Society and other national academies in Europe. It currently has about 4,000 members, including leading experts from fields such as physical sciences and technology or life sciences and medicine.

Volker Haucke earned his doctorate in 1997 at the Biozentrum (Center for Molecular Life Sciences) of the University of Basel, Switzerland, with studies he did on mitochondrial biogenesis in the research group led by Gottfried (Jeff) Schatz. Following postdoctoral research as a Fellow of the EMBO and the Human Frontier Science Program (HFSP) in the group led by Pietro De Camilli at Yale University School of Medicine, he founded his own laboratory at the University of Göttingen as a member of the EMBO Young Investigator Program. He was appointed a professor of biochemistry at Freie Universität Berlin in 2003. Since 2012, he has been the director of the Leibniz Research Institute of Molecular Pharmacology, a professor of molecular pharmacology at Freie Universität Berlin, and a member of the NeuroCure Cluster of Excellence.

Together with his team, he studies the molecular mechanisms involved in endocytosis and endolysosomal membrane dynamics and their role in cell signaling and neurotransmission. The goal of his work is to develop new strategies for acute chemical and pharmacological disruptions.

Haucke has won multiple awards and distinctions for his work, including the Avanti Award of the American Society for Biochemistry and Molecular Biology and the Feldberg Prize for 2020.

This site uses cookies and analysis tools to improve the usability of the site. More information. |